Optimizing foundational factors reduces side effect risk
TL;DR What You MUST Understand About MOTS-C MOTS-C is an exercise mimetic, and in the strictest sense is not a fat-loss peptide It activates AMPK pathways and enhances mitochondrial function, improving glucose metabolism, fat utilization, and physical performance in animal models Your bodys levels of MOTS-C decline sharply with age Animal and mechanistic data supporting its use are EXTREMELY strong No completed human clinical trials exist for native MOTS-C, so all human dosing remains experimental and based solely on animal data extrapolation Common experimental protocols use 510 mg subcutaneously 23 times per week, though individual responses vary widely Injection site reactions are the most common side effect, and long-term safety in humans is not fully understood What MOTS-C Peptide Actually Is MOTS-C is encoded inside your mitochondrial DNA

American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity
This guide covers what is actually in a MIC injection and what each component does, what the evidence supports and what it doesnt, how lipotropics compare to GLP-1s and every other option on the menu, who is a reasonable candidate, the safety profile, and where these injections legitimately fit inside a supervised medical weight loss program